Trial Profile
A prospective, phase IV study to evaluate the efficacy and safety of everolimus in liver transplant in Indian patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- Sponsors Novartis; Novartis Healthcare
- 13 Nov 2018 New trial record